Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ABIOMED, Inc. (ABMD : NSDQ)

• Company Description    Abiomed Inc. is engaged in developing, manufacturing and marketing of medical products, designed to assist or replace the pumping function of the failing heart. Number of Employees: 1,725

• Price / Volume Information    Yesterday's Closing Price: $235.75 Daily Weekly Monthly 20 Day Moving Average: 377,710 shares Shares Outstanding: 45.52 (millions) Market Capitalization: $10,730.40 (millions) Beta: 1.34 52 Week High: $379.30 52 Week Low: $226.46 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -25.31% -15.89% 12 Week -23.19% -15.56% Year To Date -34.36% -18.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 22 CHERRY HILL DR - DANVERS,MA 01923 USA ph: 978-646-1400 fax: 978-777-8411 ir@abiomed.com http://www.abiomed.com

• General Corporate Information    Officers Michael R. Minogue - Chief Executive Officer;Chairman;President and Dir Todd A. Trapp - Chief Financial Officer and Vice President Dorothy E. Puhy - Director Jeannine M. Rivet - Director Eric A. Rose - Director Peer Information ABIOMED, Inc. (ABMD) ABIOMED, Inc. (DMDS) ABIOMED, Inc. (CPWY.) ABIOMED, Inc. (EQUR) ABIOMED, Inc. (ECIA) ABIOMED, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 003654100 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 45.52 Most Recent Split Date: 10.00 (2.00:1) Beta: 1.34 Market Capitalization: $10,730.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $1.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $4.62 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 19.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: 51.08 Trailing 12 Months: 53.34 PEG Ratio: 2.69 Price Ratios Price/Book: 7.14 Price/Cash Flow: 42.72 Price / Sales: 10.40 EPS Growth vs. Year Ago Period: -6.45% vs. Previous Quarter: 2.65% Sales Growth vs. Year Ago Period: 11.86% vs. Previous Quarter: 3.32% ROE 03/31/22 - 14.47 12/31/21 - 15.19 09/30/21 - 15.80 ROA 03/31/22 - 13.02 12/31/21 - 13.64 09/30/21 - 14.12 Current Ratio 03/31/22 - 7.05 12/31/21 - 6.98 09/30/21 - 7.64 Quick Ratio 03/31/22 - 6.37 12/31/21 - 6.27 09/30/21 - 6.89 Operating Margin 03/31/22 - 19.74 12/31/21 - 20.65 09/30/21 - 21.44 Net Margin 03/31/22 - 13.23 12/31/21 - 13.26 09/30/21 - 15.32 Pre-Tax Margin 03/31/22 - 18.47 12/31/21 - 18.87 09/30/21 - 21.79 Book Value 03/31/22 - 33.03 12/31/21 - 31.48 09/30/21 - 30.43 Inventory Turnover 03/31/22 - 2.13 12/31/21 - 2.14 09/30/21 - 2.12 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©